sulfamethoxazole and trimethoprim
Generic: sulfamethoxazole and trimethoprim
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
sulfamethoxazole and trimethoprim
Generic Name
sulfamethoxazole and trimethoprim
Labeler
preferred pharmaceuticals inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
sulfamethoxazole 200 mg/5mL, trimethoprim 40 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8607
Product ID
68788-8607_ddc0cf94-05e0-42e0-9a4f-d79cfb3c1be9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214330
Listing Expiration
2026-12-31
Marketing Start
2024-03-14
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888607
Hyphenated Format
68788-8607
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sulfamethoxazole and trimethoprim (source: ndc)
Generic Name
sulfamethoxazole and trimethoprim (source: ndc)
Application Number
ANDA214330 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/5mL
- 40 mg/5mL
Packaging
- 473 mL in 1 BOTTLE (68788-8607-4)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ddc0cf94-05e0-42e0-9a4f-d79cfb3c1be9", "openfda": {"nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "unii": ["JE42381TNV", "AN164J8Y0X"], "rxcui": ["313134"], "spl_set_id": ["c6171b62-835c-465e-905e-97f70438186e"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (68788-8607-4)", "package_ndc": "68788-8607-4", "marketing_start_date": "20240314"}], "brand_name": "Sulfamethoxazole and Trimethoprim", "product_id": "68788-8607_ddc0cf94-05e0-42e0-9a4f-d79cfb3c1be9", "dosage_form": "SUSPENSION", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Sulfonamide Antimicrobial [EPC]", "Sulfonamides [CS]"], "product_ndc": "68788-8607", "generic_name": "Sulfamethoxazole and Trimethoprim", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sulfamethoxazole and Trimethoprim", "active_ingredients": [{"name": "SULFAMETHOXAZOLE", "strength": "200 mg/5mL"}, {"name": "TRIMETHOPRIM", "strength": "40 mg/5mL"}], "application_number": "ANDA214330", "marketing_category": "ANDA", "marketing_start_date": "20240314", "listing_expiration_date": "20261231"}